NOTV

Inotiv Inc. (NOTV) | Rumor.io

Inotiv

NOTV

Attention (50-day avg)0%

Attention rank (50-day avg)#4,572

Bullish sentiment (50-day avg)82%

Price to earnings ratio-0.01

Market capitalization387.3K

Earnings per share-2.48

Dividend yield (TTM)—

Revenue (annual)513M

Net income (annual)-68.6M

Social

What share of all stock conversation is about NOTV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 11

$NOTV has been delisted from Nasdaq and is now traded on the OTC market.
The company's shares have declined significantly since the June 3 8-K filing, with a 45% drop, and were already down following a Chapter 11 filing and a missed interest payment.
The delisting and trading status of $NOTV has raised questions about short seller obligations and fees associated with the delisting process.

Generated by AI

Sentiment

Of the messages about NOTV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.42% +6.44
Bearish	—	—	—	3.58% -6.44

Bullish· Jun 10

Inotiv, Inc. ($NOTV) may experience a significant short squeeze, with 300-600 million short shares needing to be covered, potentially leading to a 300-500% price increase.
A potential catalyst for a short squeeze could be the company's ability to cover at least 500-700 million naked short shares, which may lead to a rally.
Investors are advised to buy as much of $NOTV as possible, with a target price of $1, in anticipation of a potential short squeeze and subsequent price increase.

Bearish· Jun 8

Inotiv, Inc. (NOTV) has filed for Chapter 11 bankruptcy, warning shareholders that their equity will be cancelled.
The company's bankruptcy filing may lead to delisting on the NASDAQ exchange, with the ticker potentially being moved to the OTC market.
The demand for NOTV shares has decreased while the supply has increased, suggesting a downward trend for the stock.

Generated by AI

Topics

Of the messages about NOTV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0.08%
Announcements	—	—	—	88.27%
Controversies	—	—	—	0.49%
Earnings	—	—	—	0.41%
Macro	—	—	—	0%
Technical Analysis	—	—	—	10.75%

Announcements· Dec 12

Inotiv, Inc. (NOTV) issued FY22 sales guidance below estimates, causing a 23% premarket slump.
The company provided a business update and select preliminary fiscal year 2022 financial results, including a delay in releasing full financial results and quarterly conference call.
NOTV intends to file a Form 12b-25 with the SEC for a 15-day extension to file its FY 2022 Annual Report on Form 10-K.

Controversies· Jul 18

Inotiv, Inc. has entered into a settlement with the U.S. Department of Justice and the U.S. Department of Agriculture to resolve civil and administrative complaints, with no fines or penalties required.
The settlement resolves an investigation into Inotiv's past operation of the Cumberland Facility, with Envigo reaching an agreement to resolve the matter.
Inotiv shares have increased by 16% following the settlement announcement, with investors encouraged to secure counsel before an important deadline in a securities class action.

Generated by AI

Community

Of the messages about NOTV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	8.45%
Newcomers	—	—	—	91.55%

Regulars· May 14

Inotiv, Inc. has filed to delay its 10-Q report, citing ongoing cooperation with the U.S. DOJ related to an investigation, causing $NOTV to drop 12.5%.
Inotiv expects to raise "going concern" doubt and will miss the deadline to file its quarterly 10-Q report with the U.S. SEC, sending shares down 47.6% to their lowest level in seven months.
Jefferies analyst David Windley downgraded $NOTV from $11.5 to $3.75, citing a decrease in potential downside change from $7.33(175.78%) to $0.42(10.07%), with a rating of Hold.

Newcomers· Nov 18

The newcomers are focused on Inotiv, Inc.'s (NOTV) strong growth prospects, anticipating a positive outlook from preliminary FY 2025 results.
The focus is on the company's revenue projections, which are expected to drive growth, with some users waiting for the EPS hit from the recent cyberattack.
The newcomers are discussing the stock's performance in the last hour, with NOTV being one of the top performers, along with other stocks like EPSM and WKHS.

Generated by AI

WEST LAFAYETTE, Ind., July 20, 2026--Inotiv, Inc. (NASDAQ: NOTV) (the "Company", or "Inotiv"), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today the completion of its financial restructuring process and emergence from Chapter 11 protection.

2mo agoYahoo Finance

Inotiv Announces Confirmation of Plan of Reorganization

WEST LAFAYETTE, Ind., July 14, 2026--Inotiv, Inc. (NASDAQ: NOTV) (the "Company", or "Inotiv"), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the Company’s Plan of Reorganization (the "Plan"). With this approval in place, the Company expects to emerge from Chapter 11 prot

2mo agoYahoo Finance

Also Discussed

Investors talking about NOTV also mention

#	Name	Attention
1	Charles River Laboratories International, Inc.CRL	0%new
2	Sleep Number CorporationSNBR	0%new
3	Vsee Health Inc.VSEE	0%0
4	Huize Holding Ltd. ADRHUIZ	0%0
5	Hitek Global Inc.HKIT	0%0
6	Sotera Health CompanySHC	0%0
7	Tecnoglass Holdings Inc.TGLS	0%-0.02
8	Aviat Networks IncAVNW	0%0
9	Beasley Broadcast Group IncBBGI	0%new
10	Elicio Therapeutics Inc.ELTX	0%0

Inotiv Inc.

Healthcare
Diagnostics & Research

Inotiv Inc. is a prominent company specializing in contract research organization (CRO) services primarily aimed at enhancing drug discovery and development. The primary function of Inotiv is to provide comprehensive non-clinical and analytical services for pharmaceutical and biotechnology industries. These services play a critical role in the early stages of drug development, supporting the transition from discovery through clinical trials by ensuring safety and efficacy standards are met. Notably, Inotiv Inc. is involved in toxicology and pathology studies, bioanalysis, and consulting, all of which are crucial in advancing pharmaceutical research. The company’s significance in the market lies in its ability to streamline the drug development process for clients, potentially accelerating the timeline for bringing new therapies to market. Given the ever-evolving nature of medical research, Inotiv stands as a vital partner for clients seeking to navigate the complex regulatory environment while driving innovation in therapeutic solutions. Headquartered in the United States, Inotiv Inc. operates in one of the most dynamic sectors of the healthcare industry, supporting a global clientele with high-impact scientific expertise.

Website

Location

2701 Kent Avenue

West Lafayette, IN, 47906

United States

Social

What share of all stock conversation is about NOTV?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 11

$NOTV has been delisted from Nasdaq and is now traded on the OTC market.
The company's shares have declined significantly since the June 3 8-K filing, with a 45% drop, and were already down following a Chapter 11 filing and a missed interest payment.
The delisting and trading status of $NOTV has raised questions about short seller obligations and fees associated with the delisting process.

Generated by AI

Sentiment

Of the messages about NOTV that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.42% +6.44
Bearish	—	—	—	3.58% -6.44

Bullish· Jun 10

Inotiv, Inc. ($NOTV) may experience a significant short squeeze, with 300-600 million short shares needing to be covered, potentially leading to a 300-500% price increase.
A potential catalyst for a short squeeze could be the company's ability to cover at least 500-700 million naked short shares, which may lead to a rally.
Investors are advised to buy as much of $NOTV as possible, with a target price of $1, in anticipation of a potential short squeeze and subsequent price increase.

Bearish· Jun 8

Inotiv, Inc. (NOTV) has filed for Chapter 11 bankruptcy, warning shareholders that their equity will be cancelled.
The company's bankruptcy filing may lead to delisting on the NASDAQ exchange, with the ticker potentially being moved to the OTC market.
The demand for NOTV shares has decreased while the supply has increased, suggesting a downward trend for the stock.

Generated by AI

Topics

Of the messages about NOTV that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0.08%
Announcements	—	—	—	88.27%
Controversies	—	—	—	0.49%
Earnings	—	—	—	0.41%
Macro	—	—	—	0%
Technical Analysis	—	—	—	10.75%

Announcements· Dec 12

Inotiv, Inc. (NOTV) issued FY22 sales guidance below estimates, causing a 23% premarket slump.
The company provided a business update and select preliminary fiscal year 2022 financial results, including a delay in releasing full financial results and quarterly conference call.
NOTV intends to file a Form 12b-25 with the SEC for a 15-day extension to file its FY 2022 Annual Report on Form 10-K.

Controversies· Jul 18

Inotiv, Inc. has entered into a settlement with the U.S. Department of Justice and the U.S. Department of Agriculture to resolve civil and administrative complaints, with no fines or penalties required.
The settlement resolves an investigation into Inotiv's past operation of the Cumberland Facility, with Envigo reaching an agreement to resolve the matter.
Inotiv shares have increased by 16% following the settlement announcement, with investors encouraged to secure counsel before an important deadline in a securities class action.

Generated by AI

Community

Of the messages about NOTV, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	8.45%
Newcomers	—	—	—	91.55%

Regulars· May 14

Inotiv, Inc. has filed to delay its 10-Q report, citing ongoing cooperation with the U.S. DOJ related to an investigation, causing $NOTV to drop 12.5%.
Inotiv expects to raise "going concern" doubt and will miss the deadline to file its quarterly 10-Q report with the U.S. SEC, sending shares down 47.6% to their lowest level in seven months.
Jefferies analyst David Windley downgraded $NOTV from $11.5 to $3.75, citing a decrease in potential downside change from $7.33(175.78%) to $0.42(10.07%), with a rating of Hold.

Newcomers· Nov 18

The newcomers are focused on Inotiv, Inc.'s (NOTV) strong growth prospects, anticipating a positive outlook from preliminary FY 2025 results.
The focus is on the company's revenue projections, which are expected to drive growth, with some users waiting for the EPS hit from the recent cyberattack.
The newcomers are discussing the stock's performance in the last hour, with NOTV being one of the top performers, along with other stocks like EPSM and WKHS.

Generated by AI

Inotiv

Social

Jun 11

Sentiment

Bullish· Jun 10

Bearish· Jun 8

Topics

Announcements· Dec 12

Controversies· Jul 18

Community

Regulars· May 14

Newcomers· Nov 18

News

Inotiv Successfully Completes Financial Restructuring Process

Inotiv Announces Confirmation of Plan of Reorganization

Also Discussed

Inotiv Inc.

Company Information

Location

News

Inotiv Successfully Completes Financial Restructuring Process

Inotiv Announces Confirmation of Plan of Reorganization

Also Discussed

Social

Jun 11

Sentiment

Bullish· Jun 10

Bearish· Jun 8

Topics

Announcements· Dec 12

Controversies· Jul 18

Community

Regulars· May 14

Newcomers· Nov 18